These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 23602827)

  • 1. Adaptation of yellow fever virus 17D to Vero cells is associated with mutations in structural and non-structural protein genes.
    Beasley DW; Morin M; Lamb AR; Hayman E; Watts DM; Lee CK; Trent DW; Monath TP
    Virus Res; 2013 Sep; 176(1-2):280-4. PubMed ID: 23602827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation in NS5 protein attenuates mouse neurovirulence of yellow fever 17D vaccine virus.
    Xie H; Ryman KD; Campbell GA; Barrett AD
    J Gen Virol; 1998 Aug; 79 ( Pt 8)():1895-9. PubMed ID: 9714237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and biological properties of yellow fever 17D/dengue type 1 recombinant virus.
    Mateu GP; Marchevsky RS; Liprandi F; Bonaldo MC; Coutinho ES; Dieudonné M; Caride E; Jabor AV; Freire MS; Galler R
    Trans R Soc Trop Med Hyg; 2007 Mar; 101(3):289-98. PubMed ID: 17169387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation in a 17D-204 vaccine substrain-specific envelope protein epitope alters the pathogenesis of yellow fever virus in mice.
    Ryman KD; Ledger TN; Campbell GA; Watowich SJ; Barrett AD
    Virology; 1998 Apr; 244(1):59-65. PubMed ID: 9581778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yellow fever vaccine: comparison of the neurovirulence of new 17D-204 Stamaril™ seed lots and RK 168-73 strain.
    Moulin JC; Silvano J; Barban V; Riou P; Allain C
    Biologicals; 2013 Jul; 41(4):238-46. PubMed ID: 23763825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yellow fever 17D vaccine virus isolated from healthy vaccinees accumulates very few mutations.
    Xie H; Cass AR; Barrett AD
    Virus Res; 1998 May; 55(1):93-9. PubMed ID: 9712515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the genomes of the wild-type French viscerotropic strain of yellow fever virus with its vaccine derivative French neurotropic vaccine.
    Wang E; Ryman KD; Jennings AD; Wood DJ; Taffs F; Minor PD; Sanders PG; Barrett AD
    J Gen Virol; 1995 Nov; 76 ( Pt 11)():2749-55. PubMed ID: 7595382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic stability of a dengue vaccine based on chimeric yellow fever/dengue viruses.
    Mantel N; Girerd Y; Geny C; Bernard I; Pontvianne J; Lang J; Barban V
    Vaccine; 2011 Sep; 29(38):6629-35. PubMed ID: 21745519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the dengue virus major envelope protein on passaging and their localization on the three-dimensional structure of the protein.
    Lee E; Weir RC; Dalgarno L
    Virology; 1997 Jun; 232(2):281-90. PubMed ID: 9191841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yellow fever 17D virus: pseudo-revertant suppression of defective virus penetration and spread by mutations in domains II and III of the E protein.
    Vlaycheva L; Nickells M; Droll DA; Chambers TJ
    Virology; 2004 Sep; 327(1):41-9. PubMed ID: 15327896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manipulation of the yellow fever virus non-structural genes 2A and 4B and the 3'non-coding region to evaluate genetic determinants of viral dissemination from the Aedes aegypti midgut.
    McElroy KL; Tsetsarkin KA; Vanlandingham DL; Higgs S
    Am J Trop Med Hyg; 2006 Dec; 75(6):1158-64. PubMed ID: 17172386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroadapted yellow fever virus strain 17D: a charged locus in domain III of the E protein governs heparin binding activity and neuroinvasiveness in the SCID mouse model.
    Nickells J; Cannella M; Droll DA; Liang Y; Wold WS; Chambers TJ
    J Virol; 2008 Dec; 82(24):12510-9. PubMed ID: 18842715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and Nonstructural Genes Contribute to the Genetic Diversity of RNA Viruses.
    Collins ND; Beck AS; Widen SG; Wood TG; Higgs S; Barrett ADT
    mBio; 2018 Oct; 9(5):. PubMed ID: 30377281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleotide sequence of the NS5 gene of Banzi virus: comparison with other flaviviruses.
    Fulop LD; Barrett AD; Titball RW
    J Gen Virol; 1995 Sep; 76 ( Pt 9)():2317-21. PubMed ID: 7561771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The French neurotropic vaccine strain of yellow fever virus accumulates mutations slowly during passage in cell culture.
    Holbrook MR; Li L; Suderman MT; Wang H; Barrett AD
    Virus Res; 2000 Aug; 69(1):31-9. PubMed ID: 10989183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
    Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
    Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The small nuclear ribonucleoprotein U1A interacts with NS5 from yellow fever virus.
    Bronzoni RV; Madrid MC; Duarte DV; Pellegrini VO; Pacca CC; Carmo AC; Zanelli CF; Valentini SR; Santacruz-Pérez C; Barbosa JA; Lutz CS; Rahal P; Nogueira ML
    Arch Virol; 2011 Jun; 156(6):931-8. PubMed ID: 21298455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface expression of an immunodominant malaria protein B cell epitope by yellow fever virus.
    Bonaldo MC; Garratt RC; Caufour PS; Freire MS; Rodrigues MM; Nussenzweig RS; Galler R
    J Mol Biol; 2002 Jan; 315(4):873-85. PubMed ID: 11812154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of yellow fever 17DD vaccine virus in primary culture of chicken embryo fibroblasts: yields, thermo and genetic stability, attenuation and immunogenicity.
    Freire MS; Mann GF; Marchevsky RS; Yamamura AM; Almeida LF; Jabor AV; Malachias JM; Coutinho ES; Galler R
    Vaccine; 2005 Mar; 23(19):2501-12. PubMed ID: 15752837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 17D yellow fever vaccine virus envelope protein expressed by recombinant baculovirus is antigenically indistinguishable from authentic viral protein.
    Shiu SY; Morikawa S; Buckley A; Higgs S; Karunakarannair V; Blachere C; Gould EA
    J Gen Virol; 1991 Jun; 72 ( Pt 6)():1451-4. PubMed ID: 1710651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.